Izquierdo I, Dias R D
Psychoneuroendocrinology. 1984;9(1):77-81. doi: 10.1016/0306-4530(84)90024-6.
The post-training administration of ACTH1-24 (0.2 microgram/kg), human beta-endorphin (1.0 microgram/kg) or epinephrine HC1 (5.0 micrograms/kg), intraperitoneally, caused retrograde amnesia for a step-down inhibitory avoidance task in rats, and their pre-testing administration reversed this effect. The concomitant administration of the alpha 2-adrenergic receptor blocker, yohimbine HC1 (2.0 mg/kg), antagonized both the post-training amnestic and the pre-testing anti-amnestic effects of the three substances. The anti-amnestic effect of epinephrine, but not that of ACTH or beta-endorphin, was also antagonized by the alpha 1-adrenergic receptor blocker, prazosin HC1 (2.0 mg/kg). These findings suggest that alpha 2-adrenergic receptors are involved both in the amnestic and in the anti-amnestic effect of ACTH, beta-endorphin and epinephrine at the doses used, and that, in the case of the anti-amnestic effect of epinephrine, alpha 1 receptors also are involved. It seems likely that memory regulation by post-training and pre-testing ACTH and beta-endorphin requires the concomitant activity of alpha 2-adrenergic mechanisms, either central or peripheral.
训练后腹腔注射促肾上腺皮质激素1 - 24(0.2微克/千克)、人β - 内啡肽(1.0微克/千克)或盐酸肾上腺素(5.0微克/千克)会导致大鼠在一步下抑制性回避任务中出现逆行性遗忘,而在测试前注射这些物质则可逆转这种效应。同时给予α₂ - 肾上腺素能受体阻滞剂盐酸育亨宾(2.0毫克/千克),可拮抗这三种物质在训练后的遗忘作用以及测试前的抗遗忘作用。肾上腺素的抗遗忘作用(而非促肾上腺皮质激素或β - 内啡肽的抗遗忘作用)也可被α₁ - 肾上腺素能受体阻滞剂盐酸哌唑嗪(2.0毫克/千克)拮抗。这些发现表明,在所使用的剂量下,α₂ - 肾上腺素能受体参与了促肾上腺皮质激素、β - 内啡肽和肾上腺素的遗忘及抗遗忘作用,并且就肾上腺素的抗遗忘作用而言,α₁受体也参与其中。训练后和测试前给予促肾上腺皮质激素和β - 内啡肽对记忆的调节似乎需要中枢或外周α₂ - 肾上腺素能机制的协同作用。